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Abstract 
  
Malaria is caused by a parasite of the genus Plasmodium and remains the most important 
parasitic disease. The emergence of Plasmodium falciparum parasites resistant to all known 
antimalarial drugs is of major concern. New antimalarial drugs are needed, not only a drug that 
overcome the undesirable side effects of current antimalarial drugs but new highly active ones 
against the asexual stages, as well as, drugs that could also eliminate the transmissible sexual 
form of the parasite to the mosquito.  
 To test the susceptibility of the parasite to drugs a variety of sensitivity assays can be used 
to screen new compounds, such as: hypoxanthine incorporation, ELISA based assays like pLDH 
and HRP2, fluorometric and flow cytometric assays. Recently, a novel flow cytometric sensitivity 
assay based on hemozoin detection was described. Using this novel sensitivity assay new 
antimalarial compounds were screened at 1 and 3 µM. The SYBR green DNA staining assay and 
the HRP2 were also perfomed as mean of comparison. Results showed that none of the tested 
compounds presented inhibitory activity against P. falciparum strains 3D7 and Dd2 at 1 µM, 
independently of the method used. Only one of the compounds showed more than 50% inhibition 
at 3µM.  
 The flow cytometric hemozoin detection method was also assessed for its potential to 
detect gametocytes. Gametocyte may have a different depolarizing profile, based on the underlying 
hemozoin distribution. Thus, we further investigated if they could be distinguished from other 
parasitie forms based on their higher degree of depolarization. A culture enriched in gametocytes 
was FACS sorted by selecting the higher depolarizing population. Results showed that 
gametocytes were selectively present only in the high depolarizing population and not in the middle 
and non-depolarizing events.  
 Therefore, this recently described sensitivity assay based on hemozoin detection can be 
used as a novel approach to screen for new antimalarial drugs. This approach has as major 
advantages the fact that results can be obtained in only 24 h of incubation and no additional 
reagents or additional incubation times are required. Another important characteristic of this 
method is that it might be able to detect gametocytes based on the particular hemozoin distribution 
in these forms, which can lead to the use of this method to test antimalarial transmission blocking 
drugs.  
  
 
  Key-words: Malaria, antimalarial drugs, antimalarial drug resistance, in vitro sensitivity assays, 
hemozoina, flow cytometry. 
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Resumo 
 
A malária é uma doença que segundo os mais recentes dados da Organização Mundial de 
Saúde (OMS) foi responsável por cerca de  660 000 mortes e 219 milhões de casos em 2010. É a 
doença parasitária que mais mortes causa sendo a região mais afetada por esta doença a África 
subsariana, e com uma maior incidência em crianças até aos 5 anos de idade.  
A malária é causada pelo parasita do género Plasmodium. As cinco espécies que podem 
causar doença no humano são: P. falciparum, P. vivax, P. ovale, P. malariae e P. knowlesi. No 
entanto P. falciparum é a espécie responsável pelo maior número de casos e mortes por malária 
sendo também o que pode levar a uma maior severidade da doença. A malária manifesta-se por 
períodos de febres altas e calafrios, mal-estar generalizado, torpor e dor de cabeça, naúsea e dor 
abdominal, por vezes até vómitos e diarreia. No caso de doença severa esta implica anemia 
severa,  malária cerebral, síndrome de dificuldade respiratória aguda, insuficiência renal e nos 
casos mais graves a morte. 
Segundo estes factos, a maária é uma doença que levanta preocupação e tem impacto a 
nível mundial. Isto porque, por várias circunstâncias se pensou que estaríamos no caminho da 
erradicação da doença e no entanto, apesar de o número de casos e mortes ter diminuído na 
última década, esta continua a afetar milhões de indivíduos. Hoje em dia, um dos maiores 
problemas face a esta doença prende-se com o facto de P. falciparum já ter apresentado 
resistência a todos os fármacos utilizados no tratamento da doença. Entre os antimaláricos já 
usados encontram-se a quinina, a cloroquina, a primaquina, a pirimetamina conjugada com a 
sulfadoxina, a mefloquina entre outros. No entanto, as atuais directrizes para o tratamento da 
malária correspondem a terapias de combinação com recurso a derivados da artemisinina 
(“Artemisinin-based combination therapies” – ACTs). Alguns exemplos destas combinações são: 
artesunato combinado com amodiaquina, artesunato com mefloquina, arteméter e lumefantrina, 
entre outros. 
O principal objectivo detas terapias é eliminar as formas do parasita que circulam no 
sangue, pois é este estadio que conduz à manifestação da doença. Plasmodium é um parasita 
que apresenta um ciclo de vida complexo. É transmitido ao humano através da picada de um 
mosquito infectado femea do género Anopheles. Durante a picada, o parasita que existe nas 
glândulas salivares do mosquito é injetado na corrente sanguínea do humano, e dirige-se até ao 
fígado. No fígado vários parasitas vão invadir os hepatócitos, dentro dos quais maturam e replicam 
antes de serem libertados novamente na corrente sanguínea. Esta fase hepática é assintomática. 
Uma segunda vez na corrente sanguínea, os parasitas vão invadir eritrócitos dentro dos quais vão 
maturar e replicar antes de lisarem o eritrócito, libertando novos parasitas para invadir novos 
eritrócitos. Uma vez dentro de um eritrócito, um parasita segue um ciclo de maturação que 
compreende as seguintas formas: forma de anel, trofozoíto, e esquizonte. No final, irá libertar 
vários merozoítos. No entanto, ocasionalmente alguns destes merozoitos, quanto invadem um 
eritrócito vão originar formas sexuadas do parasita, os gametócitos. Os gametócitos apresentam-
se sob a forma de percursores masculinos e femininos, e são estas formas que quando em 
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circulação podem ser ingeridas por um mosquito durante uma nova picada. Após ingeridas pelo 
mosquito, estas formas vão recombinar genéticamente, dando origem a uma nova descendência 
que será novamente transmitida ao humano, recomeçando este ciclo. 
Colocam-se assim dois grandes objectivos à erradicação da malária: (i) um passa pelo 
desenvolvimento de novos agentes antimaláricos, devido à evidênca de resistência de P. 
falciparum a todos os actuais antimaláricos, incluindo os derivados da artemisinina que 
compreendem as atuais diretrizes de tratemento da doença; (ii) o outro prende-se com a 
eliminação das formas sexuadas do parasita em circulação no hospedeiro, pois eliminando estas 
formas, quebra-se o ciclo de transmissão hospedeiro-vector. 
Para a contínua pesquisa de novos compostos antimaláricos é necessário ensaios que 
detectem a sensibilidade dos parasitas aos diferentes fármacos. Os ensaios de sensibilidade 
actualmente existentes são: (i) o teste de microscópia da OMS; (ii) o teste por incorporação de 
hipoxantina; os testes baseados na detecção de anticorpos (Enzyme-Linked Immunosorbent 
Assay – ELISA) para quantificação de proteinas do parasita como a (iii) lactase desidrogenase 
(Parasite lactate dehydrogenase – pLDH e a (iv) proteina rica em histidina 2 (Histidine Rich Protein 
- HRP2); testes baseados na deteção do DNA do parasita por (v) ensaios fluorométricos e por (vi) 
citometria de fluxo. 
No entanto, como até agora não existe o teste de sensibilidade ideal, e devido a várias 
limitações de cada ensaio, novos ensaios são desenvolvidos. Um dos mais recentes baseia-se na 
deteção de hemozoina por citometria de fluxo. A hemozoína, também denominada pigmento 
malárico, é um bioproduto que resulta da destoxificação de heme livre produzido após a 
metabolização da hemoglobolina pelo parasita, e acumula-se no interior do eritrócito durante a 
maturação do mesmo. A hemozoína é um cristal com propriedades birefringentes que levam à 
despolarização da luz. Devido a esta propriedade, foi desenvolvido um ensaio de citometria de 
fluxo que detecta a hemozoína presente no interior de eritrócitos infectados. Assim, com o 
acumular de hemozoina ao longo do tempo, a deteção dos parasitas vai aumentando, havendo um 
maior número de eventos a despolarizar entre as 24h-30h de um primeiro ciclo de maturação, 
altura em que a maioria dos parasitas se apresenta como esquizonte, o estadio que também tem 
maior quantidade de hemozoína. Este ensaio permitiu detectar a sensibilidade de P.falciparum a 
vários antimaláricos e foi agora utilizado para testar a sensibilidade do parasita a novos 
antimaláricos cedidos pelo grupo do Professor Doutor Rui Moreira da Faculdade de Farmácia.  
A pesquisa da actividade dos novos compostos (“screening”) a 1 µM e a 3 µM foi realizada 
em duas estirpes de laboratório de P. flaciparum, a 3D7 (sensível à cloroquina) e a Dd2 (resintente 
à cloroquina). Após incubar a estirpe Dd2 em presença dos vários compostos, a sua inibição foi 
avaliada por citometria de fluxo, utilizando o ensaio da deteção de hemozoína e pelo ensasio da 
deteção de parasitas cujo DNA foi corado com SYBR green. Os resultados de ambos os ensaios 
demonstraram que nenhum dos 18 compostos testados a uma concentração de 1 µM levou à 
inibição do parasita. Com a estirpe 3D7 foram testados 24 novos compostos, não só utilizando os 
dois médotos de citometria de fluxo já referidos como também através de HRP2-ELISA.  Os 
resultados demonstaram que independentemente do ensaio utilizado nenhum dos novos 
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compostos apresentou actividade inibitória a 1 µM. Porém os compostos foram testados a uma 
concentração mais elevada, e a 3 µM um dos compostos demonstrou actividade inibitória (o 
composto 321). Determinou-se a concentração à qual este composto inibe 50 % do crescimento 
do parasita (CI50) de acordo com os três ensaios para detectar a sensibilidade do parasita 
obtendo-se um valor à cerca de 2 µM. No entanto, esta concentração é  demasiado alta para o 
composto poder ser posteriormente testado como agente antimalárico na fase sanguínea do 
parasita, pois os actuais antimaláricos actuam na ordem nos nanomolar (nM). 
 Para erradiacar a malária, a eliminação de gametócitos é um dos principais objectivos, de 
modo a quebrar o ciclo de transmissão da doença. Porém, existem muito poucos tratamentos que 
inibam estas formas sexuadas, e por isso é necessário continuar a investigar novos fármacos que 
actuem com mais impacto neste estadio do parasita. Para tal, uma vez mais são necessários 
ensaios que possam averiguar a sensibilidade dos gametócitos a diversos fármacos. No entanto, 
não exitem tantos ensaios para tal, como os que existem para testar a sensibilidade dos estadios 
assexuados. Uma vez que os gametócitos também apresentam hemozoína no seu interior, 
pressupôs-se que o ensaio de sensibilidade baseado na deteção de hemozoína permitisse 
também detectar gametócitos, retirando partido do facto de a hemozoína acumulada nos 
gametócitos apresentar-se de forma diferente nos esquizontes, pois ocorre sob a forma de vários 
e pequenos fragmentos ao contrário de um único e grande aglumerado. Assim, colocou-se a 
hipótese de se detectar os gametócitos por citometria de fluxo, e que estes corresponderiam a 
uma diferente população de acordo com a despolarização da sua hemozoína.  
Para corroborar esta ideia, estabeleceu-se a diferenciação de gametócitos a partir de 
culturas contínuas e posteriormente, através de análise por citometria de fluxo, os eventos da 
cultura de gametócitos foram separados (“sorting”) com base na sua depolarização. Partindo do 
princípio que os gametócitos têm mais cristais, estes podem levar a uma maior quantidade de luz 
a depolarizar, logo iriam localizar-se num nível de despolarização mais elevado do que os 
esquizontes. Assim, três populações foram separadas do seguinte modo: (i) população que não 
despolariza; (ii) população que despolariza a um nível médio (semelhante ao nivel de 
despolarização de esquizontes) e (iii) população a um nível mais elevado de despolarização. Após 
observação de cada uma das populações por microscopia, constatou-se que dos eventos 
adquiridos, os gametócitos só se encontravam na população cuja despolarização era a mais 
elevada.  
 Com este recente ensaio baseado na deteção de hemozoína foi então possivel testar a 
actividade inibitória de novos compostos antimaláricos, obtendo as mesmas conclusões que 
outros dois métodos utilizados em paralelo. Este ensaio poderá assim ser utilizado no rastreio da 
actividade de novos compostos, como alternativa aos existentes actualmente, aos quais, há 
resistências desenvolvidas pelo parasita assim como o facto de conduzirem a efeitos secundários 
indesejáveis. Em relação aos outros ensaios de sensibilidade, este método apresenta-se como um 
método rápido de obter resultados (24h) e em tempo real, sem a necessidade de adição de 
reagentes ou tempos adicionais de incubação com reagentes. Este método permitiu ainda detetar 
uma população específica do parasita, os gametócitos, os quais representam um dos principais 
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alvos para a eliminação da malária. Assim, este método poderá também ser investigado como 
ensaio de sensibilidade dirigido a gametócitos.  
 
Palavras-chave: malária, Plasmodium spp, resistência a antimaláricos, testes de sensibilidade in 
vitro, hemozoína, citometria de fluxo, fármacos anti-maláricos.  
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1. Introduction 
1.1 Introduction to Malaria  
Malaria is a parasitic blood disease that according to World Health Organization latest 
report caused an estimated 219 million cases of malaria and 660 000 deaths in 2010 
[1]
. It affects 
mostly the sub-Saharan Africa territory, and has a higher incidence in children under 5 years old 
[1]
. 
Malaria is caused by one of the five known Plasmodium spp in humans: P. falciparum, P. 
vivax, P. ovale, P. malariae and P. knowlesi 
[2]
. In general, symptoms include periodic chills and 
fevers, malaise, lethargy, headache, nausea, abdominal pain and sometimes vomiting and 
diarrhea. P. falciparum is the major strain that can cause severe disease such as severe anemia, 
cerebral malaria, pulmonary edema, acute respiratory distress syndrome and renal failure, and 
thus is the strain causing most deaths 
[3]
. 
Plasmodium has a complex life cycle 
[4]
 which comprises an asexual reproduction cycle in 
the human host and a sexual reproduction cycle in the mosquito vector (Figure 1). The cycle starts 
when an infected female Anopheles mosquito bites an individual, and injects sporozoites, present 
in mosquito’s salivary glands, into the host blood stream during its blood meal. These sporozoites 
migrate to the liver where they mature and multiply within hepatocytes. These forms are known as 
schizonts (Figure 1, point 2). This extra-erythrocytic stage is asymptomatic and usually lasts 6 days 
to 14 days, although sometimes it can last up to several months or even years in the case of P. 
vivax or P. ovale. These two human Plasmodium species can produce hypnozoites in the liver 
[5]
 
(Figure 1, point 2). Hypnozoites are a dormant form of the parasite, also called cryptic form, which 
can stay in the liver for long periods of time and are the cause of the disease relapse.  
After the liver stage, tens of thousands of merozoites will be released into the blood, where 
they will invade and develop within erythrocytes. The blood stage of infection includes asexual 
forms of the parasite that undergo repeated cycles of multiplication in erythrocytes (Figure 1 point 
3), causing parasite numbers to rise rapidly. This stage is responsible for the symptoms of malaria.  
Within the erythrocyte, the asexual forms of the parasite passes through different 
sequential maturation stages: ring, trophozoite and schizont forms (Figure 2). In the end, the 
erythrocyte ruptures and new merozoits are released and ready to infect new erythrocytes (Figure 
1, point 3). Some parasites will develop into the sexual forms, responsible for transmission, known 
as gametocytes Figure 1, point 4). The female and male gametocytes (macro-gametocyte and 
micro-gametocyte, respectively) will be ingested by the mosquito vector during its feeding, and 
sexual reproduction occurs inside the mosquito midgut before the parasite is transmitted to another 
human host and the whole cycle starts again 
[6]
. 
 
1.2 Treatment of Malaria 
Most available antimalarial drugs were designed to target the symptomatic blood stages 
and thus act only against the sexual blood forms 
[7]
. Treatment of an individual diagnosed with P. 
falciparum malaria is of great concern because contrary to the other species, it can be rapidly fatal 
[3]
. However, going forward with malaria eradication objective, medicines that block parasite 
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transmission and drugs which eliminate the asymptomatic cryptic hepatic forms of P. vivax and 
ovale, are also needed 
[8]
. 
 
1.2.1 History and overview of antimalarial drugs 
Quinine is one of the oldest known antimalarial drugs, and occurs naturally in the bark of 
cinchona trees in South America. It is an alkaloid and was first isolated in 1820 and used for many 
decades 
[9]
. During the First World War, due to quinine stocks declining, the development of the 
first synthetic antimalarial was conducted. Work with synthetic dyes led to the development of the 
acridines and the 8-aminoquinolines, such as pamaquine (and subsequently primaquine) 
[10]
.  
In the 1940s chloroquine, a 4-aminoquinoline, was introduced as an antimalarial 
chemotherapy after having been synthesized in Germany. Chloroquine was not only highly 
effective and well tolerated as treatment but was also the main drug of choice in the WHO Global 
Eradication Programme of the 1950s and 1960s 
[9]
.  
During World War II, chloroquine was only one of many antimalarials that resulted from 
scientific advances. Others were developed, and some of them focused on derivatives of 
pyrimidine. Research in this direction resulted in the development of the antifolates like proguanil. 
Then, pyrimethamine was developed shortly afterwards. Proguanil and pyrimethamine were used 
as prophylactic and therapeutic agents, despite their slow schizontocidal action. The antifolates are 
dihydrofolate reductase (DHRF) and dihydropteroate synthase (DHPS) inhibitors that disrupt folate 
synthesis in the parasite 
[10]
. Later it was discovered that in combination with pyrimethamine, sulfa 
drugs like sulfadoxine, were more effective against Plasmodium infection. However, after the 
introduction of sulfa drug-DHRF inhibitor combinations, the U.S. army developed further aryl-amino 
alcohol derivatives from quinine, such as mefloquine and halofantrine. More recently, atovaquone 
was introduced as an antimalarial drug, and is used also as prophylactic agent since inhibits not 
only the blood stages forms of the parasite but the liver stages as well 
[11]
. It is administered in 
synergy with proguanil 
[12]
. 
Most of antimalarial drugs therapeutics acts upon the asexual blood stages of parasite, like 
quinine, chloroquine, mefloquine and the antifolates (Table 1). Primaquine is the only that acts 
against liver stages parasites, more specifically only against hypnozoites, that occur in P. vivax and 
P. ovale. Tough, primaquine also inhibits gametocyte forms. 
Overall, the blood stages antimalarial drugs interfere with parasite hemoglobin degradation 
and heme detoxification, or with parasite folate biosynthesis.  Others drugs such as tetracyclines 
and clindamycin inhibit protein synthesis in the apicoplast 
[13], [14]
. 
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Figure 1 – Plasmodium life cycle and antimalarial drugs interference. Plasmodium life cycle from 
mosquito (1), through liver stage (2), blood stage (3), gametocytes (4) and these are passed again to the 
mosquito vector (5). Adapted from Baird, J.K. 2005 
[7]
. The antimalarial drugs can act upon liver forms, blood 
forms and/or gametocytes. 
 
 
 
 
 
 
 
 
 
 
Figure 2 - P. falciparum intra-erythrocytic maturation cycle. Representative images of infected 
erythrocyte with P. falciparum parasite at ring stage (1), trophozoite stage (2) and schizont (3). Then the 
erythrocyte ruptures, freeing new merozoites as well as hemozoin (4). The new merozoites invade uninfected 
erythrocytes (5). 
 
1.2.2 Current guidelines for malaria treatment 
Although the guidelines may vary somewhat, especially between affluent non-endemic 
countries and endemic countries, the first-line treatment of uncomplicated falciparum malaria relies 
on artemisinin-based combination therapies (ACTs) 
[15]
. Artemisinin comes from Artemisia annua 
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also known as qinghao, and it was long used in Chinese traditional medicine 
[16]
. However, it was 
only in the early 1970s that its potent antimalarial activity was discovered. Artemisinin and 
derivates such as arthemeter, artesunate and dihydroartemisinin, are associated with a high rate of 
recrudescence if used as monotherapy 
[17]
. This is probably related with pharmacodynamic 
properties of these agents which include fast acting but short half-lives. Therefore, they are usually 
combined with longer acting antimalarials. Artemether plus lumefantrine, artesunate plus 
amodiaquine, artesunate plus mefloquine or/and artesunate plus sulfadoxine-pyrimethamine are 
examples of ACTs. Although still not clear, artemisinins seem to affect the hemoglobin catabolism 
during parasite maturation within the erythrocyte 
[18], [19]
.  
Artemisinin and artemisinin combination therapies also have some effectiveness at reducing 
gametocyte carriage 
[20]
, although well inferior to primaquine 
[21]
. Primaquine remains the principal 
available drug for radical treatment to eliminate the cryptic liver stage forms of P. vivax or ovale 
(Figure 1, point 2). However, because of possible severe side effects like hemolytic anemia it is 
difficult to use in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd) 
[22], [23] 
(Table 1).  
 
Table 1 – Major antimalarial drugs actions 
Class Mecanisms of action Drugs Parasite stage 
Q
u
in
o
lin
e
s
 
Arylamino-
alcohols 
Inhibition of haem 
polymerization 
[24]
  
By π-π interactions of 
drug with free heme 
Quinine 
Blood-stage 
schizonticide 
Mefloquine 
Amino-
Quinolones 
Chloroquine 
Primaquine 
Liver-stage 
schizonticide, 
gametocytocide 
Antifolate 
 
Dihydrofolate reductade 
(DHFR) and 
dihydropteroate 
synthase (DHPS) 
inhibitors in the folic 
acid synthesis pathway 
[10]
 
Pyrimethamine 
Blood-stage 
Proguanil 
Artemisinines 
(sesquiterpene 
lactones) 
 
Inhibition of hemozoin 
formation; inhibition of 
parasite’s sarco-
endoplamic reticulum 
Ca2+-ATPase 
(SERCA); or generation 
of free radicals 
[18], [25] 
 
Artemether 
Blood-stage 
schizonticide, 
gametocytocide Artesunate 
Dihydroartemisinin 
Hydroxy-napthoquine 
Inhibition of electron 
transport 
[11], [26]
 
Atovaquone 
Liver-stages 
Blood-stage 
schizonticide 
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Overall, there is a need for novel antimalarial drugs that overcome the limitations of the 
currently available antimalarials. The side effects of antimalarial drugs and their lack of activity 
against liver parasites and sexual stages has presented an important concern in malaria 
eradication. 
 
1.2.3 Antimalarial drug resistance 
Since malarial drug treatment exists, Plasmodium parasites have developed resistance to 
the most of the drugs that have been used to treat malaria 
[24]
. The advent of chloroquine 
resistance was probably the most relevant, because chloroquine was thought to lead to malaria 
erradication yet, resistance appeared and spread globally 
[27]
. In the late 1950s, resistance to 
chloroquine was noted on the Thai-Cambodian border in Colombia, than in 1980 all endemic areas 
in South America were affected, and by 1989 almost all Asia and Oceania.  In Africa, chloroquine 
resistance was first documented in the east in 1978 
[28]
. Mefloquine, sulfadoxine-pyrimethamine, 
and atovaquone-proguanil, are antimalarial drugs to which P. falciparum also developed resistance 
shortly after their introduction (Table 2). However, the use of proguanil and pryrimethamine alone 
as prophilaxis had a major impact in the insurgent of parasite resistance against these drugs 
[10]
. 
 
Table 2 – Dates of introduction and first reports of antimalarial drug resistance. 
Antimalarials Introduced First reported resistance Difference (years) 
Quinine 1632 1910 278 
Chloroquine 1945 1957 12 
Sulfadoxine-pyrimethamine 1967 1967 0 
Mefloquine 1977 1982 5 
Atovaquone 1996 1996 0 
(Adapted from Wongsrichanalai, C., et al. 2002 
[28]
)  
 
1.2.4 Artemisinin drug resistance 
One of the greater concerns in malaria control is associated with the development of drug 
resistance, mainly because resistance of P. falciparum to almost all antimalarial drugs has been 
described, including to the first line treatment with artemisinin 
[29], [30]
 .  
Resistance to artemisinin is characterized by slow parasite clearance in vivo [31] (Figure 3) 
with no corresponding reductions of susceptibility detected in in vitro 
[32]
. 
Commonly, for other antimicrobial agents, resistance is defined by clinical failures and 
decreased susceptibility in vitro 
[32]
. However, for the current definition of “artemisinin resistance”, 
based on delayed clearance of parasites, neither criterion is fulfilled. However, it is still an issue of 
big concern 
[33]
. 
In this scenario, it is of great importance to continue the search for new antimalarial drugs, 
as well as the continuous surveillance of P. falciparum resistance, especially in endemic countries. 
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Figure 3 - Parasite clearance in artemisinin sensitive and resistant parasite populations. Parasite 
clearance profile of artimisinin resistant and sensitive parasite populations. A broken line at 24h shows a shift 
in clearance between populations, and arrows represent an identical slope thereafter. Abbreviations: Art = 
artemisinin (From: Ferreira, P. E., et al. 2013) 
[32]
. 
 
1.3 Antimalarial drug research 
In the antimalarial drug research area, different approaches to study P. falciparum drug 
sensitivity have been developed. There are in vivo tests, originally defined by the World Health 
Organization (WHO) in terms of parasite clearance, which comprise the follow classification: 
sensitive [S] or one of the three degrees of resistance [RI, RII, RIII] 
[34]
. Later a modified protocol 
was introduced based on the clinical outcome with the following classifications: adequate clinical 
response, early treatment failure, and late treatment failure (Table 3). There are also phenotypic in 
vitro tests that take advantage of the possibility of continuous culture of the parasite (developed in 
the 1970s) to perform the assays 
[35]
. Although molecular in vitro tests also exist, the correlation 
between genetic changes and resistance is not well known yet for most antimalarial drugs.  
All in vitro tests share the same principle: comparison of cultures incubated with different 
concentrations of the tested compound to a drug free control, yet, they differ considerably in the 
methods used to assess parasite growth or viability. 
The main phenotypic in vitro drug sensitivity assays include 
[36]
 (Table 4):  
 Light microscopy methods like the WHO microtest to assess parasite maturation. It 
requires little technical equipment, can be used for samples with low parasite densities, and usually 
requires only 24 hours of incubation. On the other hand, its biggest disadvantage is the fact that it 
is labour-intensive, subjective (inter-operator variation) and requires highly trained personal. 
 Isotope incorporation assays, such as the [
3
H]-hypoxanthine incorporation (tritium-
labeled hypoxanthine) 
[37]
. It allows a high degree of automatization and therefore is faster to 
perform than the tests based on the morphological assessment of parasite growth. On the negative 
side, it only measures metabolic activity over the second half of the parasite life cycle and implies 
work with isotopic/radioactive material. It also requires high purchase cost for infrastructure, 
equipment and thus is very badly suited for field studies. 
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(adapted from Wongsrichanalai et al. 2002 
[28]
)  
 
 Antigen detection of parasite lactate dehydrogenase (pLDH) or histidine-rich protein 
(HRP2), produced by malaria parasites during their growth and multiplication, using an Enzyme-
Linked Immunosorbent Assay (ELISA). 
 Parasite lactate dehydrogenase (pLDH) is a terminal enzyme in the Embden-
Meyerhof pathway (glycolysis) of the malaria parasite 
[38]
. Its production and accumulation can be 
used both for malaria diagnosis ex vivo and in in vitro P. falciparum cultures as indices of the 
presence and viability of the parasite. As a drawback, this assay requires monoclonal antibodies 
(mAbs) specific for pLDH, which are expensive, have limited supplies and lack an optimal 
specificity.  
 Histidine- and alanine-rich protein is produced by P. falciparum in the course of its 
growth and multiplication 
[39]
. Histidine-rich protein 2 (HRP2) levels are closely associated with 
parasite density and development, and studies have implicated HRP2 as an important factor in the 
detoxification of heme 
[40]
. This protein stability can be considered an advantage for in vitro drug 
susceptibility assays. The assessment of this protein production can be simply measured in a 
commercial available, double-site sandwich, Enzyme-Linked Immunosorbent Assay (ELISA) test 
kit. This assay, based on the HRP2 produced by P. falciparum and measured using the ELISA has 
the advantage of requiring low parasitemia (0.05%). However is an assay that requires a time 
period of drug incubation of 72 h, followed by a series of steps to detect the protein through ELISA. 
Table 3 – Classifications of in vivo antimalarial sensitivity test outcomes according to the original 
and modified protocol  
Classification Definition 
Original Classification (1973)  
Sensitive (S) 
Reduction to <25% of initial parasitemia on day 2 with smears 
negative for malaria from day 7 to the end of follow-up (28 days or 
longer for drugs with a long half-life, such as mefloquine). 
Resistance response I (RI) 
Initial clearance of parasitemia, a negative smear on day 7, followed 
by recrudescence at day 8 or more days after treatment. 
Resistance response II (RII) 
Initial clearance or substantial reduction of parasitemia (<25% of the 
initial count on day 2) but with persistence or recrudescence of 
parasitemia during days 4–7. 
Resistance response III (RIII) No significant reduction of parasitemia. 
Modified Classification (1996)  
Adequate clinical response (ACR) 
Absence of parasitemia on day 14 irrespective of fever, or absence of 
clinical symptoms irrespective of parasitemia, in patients not meeting 
ETF or LTF criteria. 
Early treatment failure (ETF) 
Aggravation or persistence of clinical symptoms in the presence of 
parasitemia during the first 3 days of follow-up. 
Late treatment failure (LTF) 
Reappearance of symptoms in the presence of parasitemia during 
days 4–14 of follow-up. 
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 Parasitemia measuring through fluorescent DNA dyes, such as SYBR green I 
[41]
, YOYO, 
PicoGreen 
[42]
, DAPI 
[43]
 and Hoechst with either spectrophotometric or cytometric readout. 
These assays take advantage of the lack of DNA in the mature RBCs, detecting the 
stained DNA from the parasite, thus assessing parasitemia in blood samples.  
 With spectrophotometric readouts, the fluorescence intensity, which is proportional 
to the amount of DNA in individual samples, is measured with a mini fluorometer, fluorescence 
spectrophotometer or fluorescence activated microplate reader. However, this method is not as 
sensitive as other methods and it requires long incubation period (48 - 96 h).  
 With the cytometric readout using a flow cytometer, which enables to assess the 
parasitemia percentage and preform double stain for a better evaluation of the parasite as 
mentioned below. 
 
Table 4 – Advantages and limitation of antimalarial drugs sensitivity assays. 
 
 
 
  
 
 Quantification 
of schizonts 
Measurement of parasite DNA 
Measurement of 
parasite proteins 
A
d
v
a
n
ta
g
e
s
 - Requires little 
equipment. 
- Automatic 
reading of results. 
- Automatic 
reading of 
results. 
- Simple, does 
not require 
specialized 
personnel. 
- Simple, does not 
require specialized 
personnel. 
 
- Accurate and 
sensitive. 
- Accurate and 
sensitive. 
- Accurate. 
- Low detection 
limit (0.05% 
parasitemia). 
L
im
it
a
ti
o
n
s
 
- Subjective 
and labor-
intensive. 
- Handling of 
radioactive 
reagents. 
- Additional 
incubation 
steps with 
reagents. 
- Additional 
incubation 
steps with 
reagents. 
- Additional 
incubation steps 
with reagents. 
- Highly trained 
personnel. 
- Additional 
incubation steps 
with reagents. 
   
   Adapted from: Rebelo, M. et al. 2013 
[49]
 – Supplement info 
 
1.4 Flow Cytometry and Malaria 
Flow cytometry is becoming particularly important for the study of malaria parasite growth 
and invasion due to the speed and amount of information it provides and also because it 
overcomes some of the limitation of existing non-cytometric methods. Flow cytometers have also 
been progressively more cost affordable and portable, conferring important features for field 
research. 
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Using flow cytometry it is possible to assess blood parasitemia after specifically staining 
the nucleic acid (DNA) of the parasites, taking advantage of the fact that normal circulating red 
blood cells (RBCs) lack nucleic acids, while reticulocytes contain only RNA. Parasitemia in blood 
samples can therefore be determined by counting and compering the ratio of RBCs which stain 
positive for DNA to the total number of RBCs analysed. As mentioned, there is an exception that 
can potentially confound cytometric analysis of malaria, which is the presence of reticulocytes 
[44]
. 
These are erythrocytes which have been recently released from the bone marrow and still contain 
small amounts of RNA and they only present at levels less than 1.5% in healthy adults. The 
presence of reticulocytes could be confused as a parasite if one was not using DNA specific stains. 
For example, acridine orange 
[44]
 and SYTO 9 
[45] 
are not specific, thus staining both DNA and RNA. 
However, the remnant RNA in the circulating erythrocytes degrades quickly and within a few days 
in in vitro cultures, leading to a small presence of this type of cell in blood samples 
[46]
. 
 Flow cytometers with more than one laser also enable the use of combinations of stains 
[45], 
[47]
 to study more aspects of the malaria parasite. The variety of different nucleic acid stains as well 
as the membrane potential stains has been combined together with additional stains to learn more 
about malaria parasite biology. Shapiro 
[48] 
described the use of a double staining to differentiate 
nucleic acids by combining Hoechst 33342 with a RNA selective stain and used this to increase 
sensitivity for cell cycle detection using flow cytometry. Pyronin Y, a homolog of acridine orange, 
was a better choice because it is more selective for double stranded RNA, does not fluoresce when 
attached to DNA, and can detect the phases of the cell growth cycle. 
With flow cytometry assays it is possible to set up different approaches for the study of 
Plasmodium parasites thus obtaining information about growth and development, allowing the 
evaluation of current drugs, tracking levels of resistance and screening for new and effective drugs 
through determination of the concentration of drugs which inhibit more than 50% (IC50) of the 
parasite growth. In these assays the goal is to determine the number of DNA positive cells in the 
presence of different concentrations of drugs, all of which is compared to a drug-free control. 
 
1.5 Hemozoin detection by Flow Cytometry 
To overcome some of the drawbacks of the available in vitro tests referred above, a novel 
flow cytometric sensitivity test for P. falciparum has been proposed recently 
[49]
. This test is based 
on the detection of hemozoin (Hz). 
Hz crystals are formed during the intra-erythrocytic stage (Figure 2), when the parasite 
digests hemoglobin to obtain amino acids, iron and space to grow 
[50]
. As a result of this digestion 
free toxic heme is produced and detoxified by the parasite that converts it into Hz 
[51]
.  
Hz, also known as malaria pigment, is a paramagnetic, birefringent pigment that 
depolarizes light and therefore it can be detected using optical methods such as flow cytometry 
[52]
.  
In P. falciparum Hz is detectable at developmental erythrocyte stages beyond the ring 
form, which include trophozoites (Figure 4 - A and D), schizonts (Figure 4 - B and E), and also 
gametocytes (Figure 4 - C and F). However, in mature schizonts, Hz crystals aggregate as they 
start to appear and form a big clump. On the other hand, in the gametocytes, Hz pigment does not 
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form an agglomerate and instead it seems to be more disperse (Figure 4), and also present in 
Garnham bodies 
[53]
. 
A)  
B)  C)  
D)  
E)  F)  
Figure 4 – Hemozoin within P. falciparum. In A) and D) the thin arrow point to a ring form and the thick 
arrows points to young trophozoites. B) and E) are schizont forms. In C) and F) a gametocyte is 
presented. From A)-C) light microscopy images. From D)-F) depolarization microscopy images where it is 
possible to distinguish bright white spots of depolarizing Hz crystals. Smears were stained with 10x 
Giemsa, amplification (1000x). 
 
Consequently Hz can be considered an optimal parasite maturation indicator since its 
amount increases as the parasite matures (Figure 5). 
Due to the fact that Hz is birefringent it rotates the plane of polarized light, a process called 
depolarization, which is possible to detect by flow cytometry. LASER light, commonly used as a 
light source in flow cytometers, has polarized light. Thus, by placing a polarization filter 
orthogonally (90º rotated) to the plane of the LASER light in front of a second Side-Scatter (SSC) 
detector, allows to detect depolarized light and consequently Hz (Figure 6) 
[54]
.  
With a small modification of a CyFlow® Blue (Partec, Münster, Germany), creating two 
SSC detectors, using a 50%/50% beam splitter (Figure 6) it was possible to develop a drug 
sensitivity assay based on the detection of Hz depolarization. It allows the detection of cells with Hz 
relatively to a total number of cells, thus assessing the percentage of parasites that maturate. 
Because the majority of the available antimalarial drugs act on the intra-erythrocytic stage of the 
malaria infection and, moreover, some of them act directly upon Hz formation it appeared possible 
to establish an accurate and reliable sensitivity assay based on the measurement of infected RBCs 
containing of Hz. Afterwards it was proved that the flow cytometric Hz detection allowed to 
determine the inhibitory effect of antimalarial drugs 
[49]
.  
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Figure 5 – Parasite growth and maturation detection. Red line: detection of depolarization during 
incubation time. Through the first 24 to 30 hours the percentage of depolarizing events increases because 
more and more parasite presents Hz within the food vacuole. Green line: detection of parasite DNA using 
SYBR green I stain. The inicial parasitemia is maintained through the first 24 to 30 hours before the 
erythrocyte lyse  and release new merozoits increasing SYBR green detection due to reinvasion and 
increased parasitemia. Parasite intraerythrocityc maturation. 1 – Ring form; 2, 3 – Throphozoite form; 4,5 – 
Schizont stage; 6 – Erythrocyte lyse and release of new merozointes; 7 – Ring form again in a red blood cell 
reinvaded by more than one merozoite/parasite. Graph adapted from: Rebelo, M. et al. 2012 
[52]
; parasite 
images adapted from CDC: Diagnostic findings 
(http://www.dpd.cdc.gov/dpdx/HTML/ImageLibrary/Malaria_il.htm last accessed 23.10.13) 
 
1.6 Specific Gametocyte detection for drug testing 
The development of drugs that also act against the sexual forms of the parasite and thus 
block transmission is of great importance, especially considering the new eradication agenda 
[55]
. 
However, very few methods exist to test the drug sensitivity of gametocytes 
[56], [57], [58]
, certainly as 
compared to the ones available for asexual intra-erythrocitic stages 
[36]
. One problem may be the 
required culture methods to induce gametocytes. These culture methods imply selective pressure 
to the development of the sexual stages of the parasite, such as low hematocrit, a low parasitemia 
or drug treatment 
[59], [60], [61]
. However, it is not straightforward to detect gametocytes in a mixed 
culture of sexual and asexual forms, a reason why assays often use enriched gametocyte cultures 
[57]
. 
Gametocytes contain Hz, which is distributed in the form of many small crystals, contrary to 
the large, usually single crystal observed in schizonts (Figure 4). Thus it appears possible that the 
proposed flow cytometric assay for Hz detection might also allow the detection of gametocytes, 
based on the presence of a population with higher levels of depolarization than that observed in 
schizonts. Because Hz in gametocytes does not agglomerate and is dispersed (Figure 4 - F), it 
probably has a higher degree of side scatter than a single crystal, even if the total amount of Hz 
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was the same. Thus, if gametocytes could be recognized as a separate population, distinct from 
schizonts, this approach might open the way for the development of a novel drug sensitivity assay 
to assess drug effects against the sexual forms of the parasite. 
 
 
Figure 6 – Adapted flow cytometer which allows detection of depolarized side-scatter. A.: Five 
parameter CyFlow® flow cytometer with a blue laser (488nm) excitation, and detectors for forward scatter 
(FSC), side scatter (SSC), depolarized side scatter (dSSC), green fluorescence (FL1), and red fluorescence 
(FL3). B.: Two SSC detectors were created, with a 50%/50% beam splitter between them. A polarization filter 
was placed orthogonally (horizontal) to the polarization plane of the laser light (vertical), in front of one of the 
SSC detectors, allowing the detection of depolarized side scatter. Adapted from Frita, R. et al. 2011 
[54]
. 
 
2. Objectives 
The primary objective of this study was to assess the potential of the novel flow cytometric 
method for Hz detection for the screening of new antimalarial compounds against P. falciparum 
blood stages. Newly synthesized compounds were screened and compared using two other 
methods. 
The secondary aim was to evaluate if gametocyte cultures could be established and if 
gametocytes could be specifically detected using the same recently proposed flow cytometric 
method based on Hz detection. 
 
A. 
B. 
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3. Materials and Methods 
 
3.1 Culture media, solutions and reagents 
 
3.1.1 Malaria complete parasite medium (MCM): is composed by 500 mL of RPMI 1640 (1x, 
without L-glutamine, with NaHCO3) (Gibco
TM
, Life Technologies, Madrid, Spain) supplemented with 
12 mL of HEPES Buffer Solution at 1 M (Gibco
TM
, Life Technologies, Madrid, Spain), 500 µL of 
gentamicin at 50 mg/mL (Gibco
TM
, Life Technologies, Madrid, Spain), 5 mL of L-glutamine at 200 
nM and 50 mL of 10x AlbuMAX II®. 
3.1.2 10x AlbuMAx II® solution: 25 g of Albumax II® was dissolved in 500 mL of an aqueous 
solution with 5.2 g RPMI 1640 (with L-glutamine, without NaHCO3), supplemented with 500 µL of 
gentamicin (50 mg/mL), 2.98 g HEPES, 1.67 g of sodium bicarbonate, 1 g of glucose and 0.1 g of 
hypoxanthine, pH adjust to 7.2 – 7.4 and filtered 0.22 µm. All reagents were obtained from Life 
Technologies (Madrid, Spain) except HEPES which was purchased from VWR (Carnaxide, 
Portugal). 
3.1.3 1X Phosphate-buffered saline (PBS 1x): 10x PBS pH 7,2 (Gibco
TM
, Life Technologies, 
Madrid, Spain) was diluted 1:10 in filtered distilled water, obtained with Milli-Q Synthesis Q-Gard® 
water purification system (Millipore, Billerica MA, USA) or using ultrapure DNA/RNA free water 
from Gibco
TM
, Life Technologies, Madrid, Spain. 
3.1.4 Sorbitol 5%:  5 g of D-sorbitol (Sigma-Aldrich, Life science) dissolved in 100 mL of distilled 
water, then filtered 0.22µm.  
3.1.5 Cryoprotective solution: constituted by 57% of glycerol, 16 g/L of sodium lactate (VWR, 
Carnaxide, Portugal), 300 mg/L of potassium chloride and 25 mM of sodium phosphate pH 6.8.  
3.1.6 Chloroquine: stock solution of 12.8 µM prepared chloroquine (Sigma-Aldrich, Life science) 
3.1.7 Paraformaldehyde (PFA) 2%: paraformaldehyde at 16% (Electron Microscopy Sciences) was 
diluted 1:8 in PBS 1.2 X, to obtain PFA at 2%. 
 
3.2 P. falciparum in vitro cultures 
3.2.1 P. falciparum continuous cultures maintenance 
P. falciparum strains 3D7 and Dd2 were obtained from Malaria Research and Reference 
Reagent Resource Center (MR4; Manassas VA, USA). These strains were grown in continuous 
culture using uninfected red blood cells (RBCs) from healthy donors were isolated from buffy coats 
obtained from Instituto Português do Sangue. Buffy coats were washed 3x with RPMI 1640 (1x, 
without L-glutamine, with NaHCO3) and centrifuged for 5 min at 1800 rpm without applying the 
brake, allowing the separation of RBCs from white blood cells and plasma. Isolated RBCs were 
stored at 4ºC for a maximum of 2-3 weeks. Continuous P. falciparum cultures were incubated at 
37ºC in a 5% CO2 atmosphere. Culture medium was changed on a daily basis and the parasitemia 
was kept at around 0.5% and the hematocrit at 5%.  
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3.2.2 Giemsa staining of blood smears 
To assess the parasitemia of the cultures, blood smears were prepared every day and 
stained with Giemsa. The culture medium was removed and a small volume of culture blood was 
used to do a thin smear. The smear was fixed in absolute methanol, (Merk, Lisbon, Portugal) by 
dipping the slide for 30 s in a 50 mL falcon with absolute methanol, air-dried and stained with 
Giemsa at 10x (previously diluted 1:10 in PBS 1x) (Merk, Lisbon, Portugal) for 20 min. Then the 
slides were rinsed off with tap water and air-dried before observed by bright field microscopy under 
oil immersion. The parasitemia was estimated by counting the total RBCs and infected RBCs on 
eight different fields at a 1000x magnification/amplification. If the parasitemia was higher than ~2%, 
it would be lowered by adding a volume of uninfected RBCs equal to the amount of RBCs 
discarded from the culture. 
 
3.2.3 Culture synchronization 
Cultures were synchronized to obtain parasites at the same developmental stage. Cultures 
with a majority of ring-form parasites and a parasitemia higher than 2% were used. A volume of 10 
mL of sorbitol 5% was added to the RBCs, after removing the medium, and then transferred to a 50 
mL falcon and incubated for 10 min at room temperature after which it was centrifuged at 1800 
rpm, for 5 min without brake, also at room temperature. After that, the supernatant was discarded 
and the RBCs pellet was washed two times in 35 mL of RPMI 1640 (1x, without L-glutamine, with 
NaHCO3) by centrifugation (1800 rpm, 4 min, without brake, room temperature). In the end, in a 
culture flask, pelleted RBCs were diluted to 5% hematocrit in MCM and incubated at 37ºC and 5% 
CO2 atmosphere.  
 
3.2.4 Frozen stocks of P. falciparum 
When necessary, P. falciparum cultures were frozen in a cryoprotective solution and stored 
at -80ºC. From a highly parasitized culture (> 2% parasitemia), with the majority of the parasites in 
ring form, the medium was removed by centrifugation (6 min at 1800 rpm). To the remaining 
volume of pellet cells, 0.33 and then 1.33 volumes of cryoprotective solution was added slowly, 
drop by drop, while mixing the tube gently. 
To reuse cryoprotected-frozen vials, after thawing them for a few minutes at room 
temperature, the content was then transferred to a 50 mL falcon tube. To this volume, 0.1x 
volumes of 12% sodium chloride (NaCl) was added, followed by 10x volumes of 1.6% NaCl slowly, 
dropwise while shaking the tube gently. Then the tube was centrifuged for 3 min at 1800 rpm at 
20ºC. The supernatant was removed and the pellet was resuspended in 10x the volume of RPMI 
1640 (without L-glutamine, with NaHCO3) and centrifuged again for 3 min at 1800 rpm. In the 
end, the pelleted RBCs was resuspended in MCM and transferred to a culture flask. Uninfected 
RBCs were added if needed to obtain a 5% hematocrit and the culture flask was incubated at 37ºC 
in a 5% CO2 atmosphere. 
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3.3 Antimalarial drugs sensitivity assays 
3.3.1 Inhibition of Chloroquine (IC50 determination) – Influence of Oxygen 
 The influence of oxygen (O2) on parasite’s growth was assessed by determining the 
chloroquine 50% inhibitory concentration (IC50) against P. falciparum 3D7 strain in different 
atmospheres.  
 To determine the IC50, two plates with serial dilutions (6, 12, 25, 50 and 100 nM) of 
chloroquine were prepared.  The plates followed the procedure established in point 3.3.2 to 
analyse the inhibitory effect. However, one plate was incubated in a low O2 atmosphere incubator 
(Galaxy® 14 S, Eppendorf line of New Brunswick™) with 5% CO2, 5% O2 and 90% N2, and the 
other was incubated in a standard CO2 incubator (Thermo Scientific, Heraeus® HERAcell®), with 
5% CO2 and the O2 levels around 21%, as present in Earth’s atmosphere. 
 
3.3.2 Flow Cytometric Assays – General protocol 
For this assay two controls were used: a growth control (without compound – drug free 
control) and a non-infected control (erythrocytes without parasite – uninfected control). In the 
screenings of compounds from Faculdade de Farmácia da Universidade de Lisboa (FFUL) 
chloroquine at a concentration of 100 nM (2x the determined IC50) was also used as a control.  
Ring-stage synchronized cultures were used. Compounds were prepared in MCM 2x 
concentrated to the concentration to be tested. In a 96 well-plate 100 µL of compound and a blood 
suspension, previously prepared from the synchronized culture at 1% parasitemia and a 5% 
hematocrit, were added to the respective wells. Thus, each well had a final hematocrit of 2.5%, with 
1% parasitemia and the compound concentration to test (Figure 7). MCM was added to the drug 
free and uninfected controls. The assay was performed in triplicates.  
Plates were incubated for 48 h, at 37ºC in a 5% CO2 atmosphere, and flow cytometric 
measurements were performed at 0 h, 24 h and 48 h of incubation. At each time point, the 
percentage of depolarizing events and SYBR green positive events (parasitemia) was assessed. 
To measure parasitemia, samples were stained with SYBR® Green I (Sigma) at 1x (previously 
diluted 1:10000 in PBS 1x) in the proportion of 1:10 (5 µL of the sample from each well plus 50 µL 
of SYBR green 1x). Then incubated for 20 min in dark and room temperature. After this period of 
incubation 900 µL of PBS 1x were add to each sample tube before analysis in the CYFlow® 
(Partec®, Münster, Germany) where a total of 100 000 events were acquired. 
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Figure 7 – Flow cytometric assay preparation. Work solutions were prepared from a 5 mM stock compound 
(1) and distributed in a 96 well plate (2). Blood suspension in 1:1 proportion, was added to the wells (3). 
Uninfected and drug free controls were also included. The 96 well plate was set with a final 2.5% hematocrit 
and 1 % parasitemia was incubated at 37ºC in a 5 % CO2 atmosphere (4). Samples from each well stained 
with SYBR green I (5) before and analysed by flow cytometry (6). Sample analysis was performed at 0 h, 24 h 
and 48 h of incubation (7). Data was analysed using the FlowJo software (8). 
3.3.3 Screening novel compounds from Faculdade de Farmácia  
 The inhibitory potential of 24 new compounds obtained from FFUL (Professor Rui Moreira’s 
group) was investigated. The compounds are quinazoline derivatives (Table 5). The action of these 
compounds against P. falciparum 3D7 and Dd2 strains was determined. The screening was 
performed using cut-off concentrations of 1 µM and 3 µM. Inhibitory activities of the compounds 
was assessed by flow cytometric and HRP2-ELISA assays, described in 3.3.2 and 3.3.6. 
Chloroquine at 100 nM, twice the determined IC50 concentration, was used as an internal control. 
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Table 5 – Chemical structure of the quinazoline derivative screened compounds as well as from 
chloroquine, artemisinin and pyrimethamine as comparison. 
 
 Quinazoline 
 
  
ABJ1 AD3 AD6 
   
AD20 AD26 AD34 
  
 
ASR 252 ASR 256 ASR 291 
   
ASR 292 ASR 294 ASR 295 
   
ASR 299 ASR 300 ASR 304 
 
  
ASR 305 ASR 306 ASR 317 
   
ASR 321 ASR 322 ASR 323 
18 
 
 
  
ASR 327 ASR 338 ASR 341 
Example of antimalarial drugs structure: 
 
 
 
Chloroquine Artemisinin Pyrimethamine 
 
 
3.3.4 Flow cytometer 
The flow cytometer, the CyFlow® (Partec®, Münster, Germany), used in the assay is a five 
parameter flow cytometer with a blue laser (488 nm), adapted to detect depolarizing events. The 
optical bench include detectors for: forward scatter (FSC), side scatter (SSC), green (FL1 - band 
pass 535/45 nm filter) and red fluorescence (FL3 - long pass 610 nm filter), as well as a detector 
for depolarized side scatter, used to detect infected red blood cells containing Hz (Figure 6).  
Flow cytometry enables the counting and the analysis of multiple parameters of individual 
cells within heterogeneous populations. As a cell passes through the laser it will refract or scatter 
light at different angles. Light scattered in the forward direction (0º angle), is quantified in the FCS 
detector and usually a measure of particle size. Light that is scattered to the side (at 90º angle) 
indicates the granularity and structural complexity inside the cell. The depolarized side scatter 
detects light which has been scattered at 90º and depolarized. For this, a polarization filter, 
perpendicularly positioned to the incident polarized laser beam is placed in front of the detector 
blocking out scattered light which remains in its original polarization plane. 
 
3.3.5 Flow cytometric assays - results analysis 
Flow cytometric data was analysed by using FlowJo (version 9.6.2) software. The gating 
strategy was established by comparing the uninfected RBCs and P. falciparum infected RBCs 
populations at each time point (Figure 8).  Drug effects were assessed by comparing the 
percentage of depolarizing events or percentage of SYBR green positive events between the drug 
free control and the drug treated samples.  Depolarization assay results were assessed at 24 h, 
when most of the parasites are schizonts, which contain Hz. The SYBR green assay results were 
determined at 48 h, the time point when reinvasion of uninfected RBCs already occurred and the 
parasitemia has increased.  
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Figure 8 - Gating strategy. At 24 h of incubation, depolarization is measured and a gate was established 
according to the existing population of events that depolarize in the drug free control and that are absent in the 
uninfected control. At 48 h of incubation, the SYBR green positive (SG+) events were assessed by 
establishing a gate around the detected population in the drug free control that is absent in the uninfected 
control. After setting the gates they were applied to the data acquired for the tested compounds. 
 
3.3.6 Histidine-rich protein-2 sensitivity assay 
The histidine-rich protein 2 (HRP2) ELISA was performed to corroborate the flow 
cytometric results using the P. falciparum strain 3D7. For this assay a growth control (without 
compound) was used as well as an effective concentration of chloroquine at 100 nM as a control 
for inhibition.  
3.3.2.1 Pre coating protocol: 
Primary IgM antibody (MPFM-55A, Immunology Consultants Laboratories, Inc, Newberg, 
OR, USA) was diluted to 1 µg/mL concentration in PBS 1x, and 100 μL was transferred to each 
well of 96 flat-bottom well-plates. The plates were sealed and incubated at 4ºC overnight. After this, 
plates were pad-dried and 200 μL of blocking solution (2% bovine serum albumin (Sigma, CAS No. 
9048-46-8) solution in PBS 1x) was added to each well and the plates were incubated for 2 h, at 
room temperature. Then, plates were washed 3x with washing solution (PBS/Tween 20 [0.05%]) 
and pad-dried. Finally, the plates were sealed airtight and frozen at -20ºC. 
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3.3.7 HRP2-ELISA Sample analysis 
From a synchronized culture, a blood suspension with a final hematocrit of 1.5% and a 
parasitemia of 0.05% was prepared. The blood suspension was distributed in a 96 well plate, 
together with the compound at the concentration to be tested. The plate was incubated at 37ºC in a 
5% CO2 atmosphere for 72 h. At the end of incubation plates were frozen at -20ºC until the HRP2 
ELISA was performed. 
To perform the ELISA , plates were freeze and thawed twice and 100 µL of the lysed 
sample was transferred to a 96 well-plate pre-coated with MPFM-55A antibody (Immunology 
Consultants Laboratories, Portland, USA) and incubated for one hour at room temperature. Plates 
were washed three times with washing solution (Tween 20 at 0.05%), then 100 µL of the secondary 
antibody at 0.1 µg/mL, MPFG-55P (Immunology Consultants Laboratories, Portland, USA) was 
added and plates were incubated for another hour. Plates were washed again and incubated with 
the 100 µL of chromogen, TMB One (Biotrend, Köln, Germany) for 5 to 10 min, at room 
temperature, in the dark. The reaction was stopped by adding 50 µL of sulphuric acid at 1 M 
(Merck, Darmstadt, Germany). Finally, the absorbance at a wavelength of 450 nm was immediately 
determined using the Infinite M200 plate reader (Tecan, Mannedorf, Switzerland). 
 
3.3.8 50% inhibitory concentration determination of selected compounds 
The 50% inhibitory concentration (IC50) was determined for chloroquine in both 
atmospheres, and for three of the FF compounds.  
The IC50 values for chloroquine were calculated based on 2-fold serial dilutions (6, 12, 25, 
50 and 100 nM). The inhibitory effect was assessed by the flow cytometric detection of Hz and 
SYBR green, as explain above in 3.3.2. 
IC50 values were determined for the compound 321, which had been previously reported to 
have an inhibitory activity at 3 µM, and for two other compounds that were randomly selected (256 
and 291). Concentrations of 1, 2, 4, 6, 8 µM were used for all three compounds. An additional 
concentration of 10 µM was used for compounds 256 and 291. 
The SigmaPlot software from Systat Software Inc. (SSI) (San Jose, California) was used to 
trace the dose-response curves of the acquired data, in order to calculate the IC50 values.  
 
3.4 Gametocyte cultures 
Gametocytogenesis is only induced in in vitro cultures when the parasites present in the 
culture are “stressed”. For that, culture conditions were modified to induce stress in the asexual 
parasites, and two methods were experimented (A) and (B): 
 
3.4.1 Culture Method A 
Starting with a 5% hematocrit, culture medium was changed every day until a 2% - 3% 
parasitemia was reached. At this point the hematocrit was decreased to 2.5%, representing the 
“stressing factor” to induce the gametocyte culture. Every day until day ten, medium was changed 
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daily and cultures were monitored by flow cytometry, as well as by microscopic observation of thin 
blood smears. 
 
3.4.2 Culture Method B 
In a recently synchronized culture, the hematocrit was reduced to 2.5% and the 
parasitemia to 0.7%, corresponding to day one. Additionally to this “stressing factor”, the medium 
was not changed until day four. On this day, culture medium was changed and replaced by a 
suspension of lysed RBCs that corresponded to twenty percent of the final culture volume. This 
suspension consisted of RPMI 1640 with lysed RBCs which were frozen and thawed at least twice, 
in 1:1 proportion. The medium was changed on days six and eight and thereafter on a daily basis. 
Flow cytometric acquisitions as well as blood smear were done every day until day ten. 
 
3.4.3 Erythrocytes fixation using paraformaldehyde 
Cells were centrifuged to remove the culture medium. A suspension of P. falciparum 
infected RBCs with a 50% hematocrit was prepared. A volume of 5.5 mL of paraformaldehyde 
(PFA) 2% (previously diluted 1:8 in PBS 1.2x) was added to 250 μL of the infected RBC 
suspension. The same procedure was performed using uninfected erythrocytes. Samples were 
incubated for 2 h at 37ºC in a water bath. Subsequently, they were centrifuged for 3-5 min at 1800 
rpm. The supernatant was discarded and the pellet was re-suspended in PBS 1x. 
 
3.4.4 Sorting Gametocyte cultures 
The MoFlo (Beckman Coulter, Fort Collins, USA) cytometer is a high speed sorter with an 
open architecture. This enables many different configurations based on the modularity which meet 
the diverse sorting applications. For example, it is easy to include polarizing filters in any light-path 
and thus create depolarized SSC detectors. 
After fixing the erythrocytes, the gametocytes were sorted in a MoFlo cytometer according 
to its SYBR green fluorescence and depolarization degree. First, the SYBR green positive 
population was selected and its depolarization was analysed. In the depolarization plot three gates 
based on the depolarization degree were established: (i) non-depolarizing events, (ii) medium 
depolarizing events and (iii) high depolarizing events (Figure 9). Cells within these gates were 
sorted into separate tubes. The purity of sorted cells was assessed by reanalysing each sorted 
population in the MoFlo. 
Sorted cells were left to sediment overnight. Then, after removal of most of the 
supernatant, a small volume of cells were transferred onto a slide and analysed immediately by 
microscopy. Pictures of each population were taken using light microscopy and depolarizing 
microscopy. 
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Figure 9 – Sorting gating strategy. 
SYBR green positive population was plotted based on their depolarized side scatter and side scatter. Three 
gates were established according to the depolarization degree:  i) non-depolarizing events, ii) medium 
depolarizing events and iii) high depolarizing events. Cells within these gates were sorted using a MoFlo 
(Beckman Coulter, Fort Collins, USA). 
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4. Results 
4.1. Baseline Chloroquine IC50 determination for screening 
 The chloroquine (CQ) concentration at which 50% of the parasite growth is inhibited was 
determined. The obtained value was used to choose the concentration of the CQ would be used as 
a control in the screening assays of the new compounds. 
 CQ’s IC50 was determined using the P. falciparum 3D7 strain growing under two different 
atmosphere: both containing 5% CO2, one at a high oxygen percentage (~21% O2) and the other at 
a low O2 percentage (5% O2). 
After the flow cytometric measurements it was possible to determine the CQ’s IC50 for both 
atmospheres. Results obtained according to the depolarization detection at 24 h of incubation, and 
the SYBR green stain detection method at 48 h are shown in Table 6. 
 
Table 6 – Chloroquine IC50 (nM) 
 Depolarization SYBR green 
High oxygen incubator (~21% O2) 53 65 
Low oxygen incubator (5% O2) 41 41 
 
The results showed that the IC50 was higher when the culture was incubated in the 
standard CO2 incubator with ambient atmosphere (~21% O2). Despite these observed differences, 
the magnitude was considered to be sufficiently small, that a concentration of 100 nM CQ was 
chosen for the subsequent experiments, constituting about 2x IC50. Furthermore, the differences 
were considered to be within a range which would allow to perform all further experiments in the 
standard CO2 incubator (~21% O2). It is possible to find in Table 7, various CQ IC50 values were 
reported by different authors using different methods in the nM range. 
The 100 nM value was chosen, because the parasite would be sufficiently inhibited (> 
50%), however, the inhibition would not be complete and, as such, allow to observe a slight growth. 
In fact, the 90% inhibitory concentrations (IC90) obtained in this experiment were of 85 and 100 nM, 
for the depolarization and SYBR green detection assays, respectively.  
 
Table 7 – Chloroquine IC50s against P. falciparum 3D7 strain by different in vitro sensitivity asssays 
[3]-Hypoxanthine 
incorporation 
WHO schizont 
maturation test 
SYBR green I 
plate assay 
HRP2 assay 
15.7 nM  14.79 nM  8.1 nM  7.5 nM  
6 nM  
 
22.2 nM  9.7 nM  
9.7 nM  
 
16 nM  
 
11.3 nM  
 
11.54 nM  
 
18.7 nM 
   
9.6 nM  
   
29.6 nM  
   
Adapted from: Rebelo, M., et al. 2013 
[49]
 supplementary info 
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4.2 Compounds screening at 1 µM against P. falciparum strain Dd2 
Some of the compounds from the FFUL had been screened elsewhere using the CQ 
resistant Dd2 strain and had shown no effect at the screening concentration used (1 µM). Thus, to 
confirm these results, eighteen compounds from FFUL were tested at the same screening 
concentration of 1 µM against the P. falciparum Dd2 strain. The results were normalised in relation 
to the drug free control, which was considered to be 100% of parasite growth, as shown in Figure 
10. 
As expected, chloroquine at 100 nM showed no inhibitory effect because the strain is 
chloroquine resistant.  
Results obtained with the depolarization assay showed that compounds ABJ1, AD6, AD26, 
338 and 341 had a slight inhibition effect, however, none of the compounds exhibited an inhibition 
of parasite growth greater than 23%. Contrary to this, the SYBR green detection assay indicated 
that none of the tested compounds had inhibitory effects against the Dd2 strain at 1 µM. Overall, 
both assays (depolarization and SYBR green detection) allowed to confirm that none of the 
screened compounds had any relevant inhibitory action against P. falciparum Dd2 at 1 µM 
concentration. 
Figure 10 – Compounds activity tested at 1 µM against P. falciparum Dd2.  
Results from depolarization detection measured at 24 h, and SYBR green detection measured at 48 h. The 
results are expressed as normalized percentage, relative to the drug free control considered to represents 
100% maturation or complete replication. Legend: UI – Uninfected; DF – Drug free; CQ100 – Chloroquine at 
100 nM. 
 
4.3 Compounds screening at 1 µM against P. falciparum strain 3D7 
The completely sensitive strain 3D7 was investigated to rule out the hypothesis that 
inhibitory effects may not be detected when using a CQ resistant strain. 
The same compounds which had been tested against Dd2 and some further novel 
compounds, also obtained from FFUL, were tested against this strain. In total, 24 compounds were 
tested at 1 µM against the 3D7 strain. Furthermore, the already validated HRP2-ELISA in vitro 
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sensitivity assay was used to validate the results obtained by the Hz depolarization and the SYBR 
green detection assays. 
 According to the results shown in Figure 11, none of the tested compounds had an 
inhibitory effect in any of the three assays as compared to the CQ control, which inhibited more 
than 50% of the parasite’s growth. In general, parasite growth was at least 80% or more for all 
tested compounds, in comparison to the drug free control. Although, similar trends for inhibition 
were observed between the three performed methods, there were some variations in the detected 
growth percentage between methods. For example, in the HRP2-ELISA, the growth percentage 
observed for all the compounds is slightly lower, as compared to the other methods. On the other 
hand, this assay seemed to have a more coherent result (less variability) between the compounds. 
 
 
Figure 11 – Compounds activity tested at 1 µM against P. falciparum 3D7.  
Results from depolarization detection measured at 24 h, SYBR green detection measured at 48 h and the 
HRP2 assay measured at 72 h of incubation. The results are expressed as normalized percentage, relative to 
the drug free control considered to represent 100% maturation or complete replication. Legend: UI – 
Uninfected; DF – Drug free; CQ 100 – Chloroquine at 100 nM. 
 
4.4 Compounds screening at 3 µM against P. falciparum strain 3D7 
To exclude some compounds that might have an inhibitory effect just above 1 µM, another 
set of experiments were conducted, where all 24 compounds were tested at a higher concentration 
of 3 µM against the P. falciparum 3D7 strain. The three sensitivity assays were performed. 
Results presented in Figure 12, shows that most of the compounds even at 3 µM have no 
inhibitory effect, regardless of the assay performed. The exceptions were the compounds 321 and 
322. However, only compound 321 appeared to have an inhibition greater than 50%. To investigate 
this further, this compound (321) and two others were formally investigated to determine the IC50 
value (next section – see point 4.5).  
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However, as already observed at 1 µM, there were some variations in the percentage of 
growth between methods. For instance, the compound 292 had a higher growth percentage in the 
depolarization assay than what was observed in the other two methods. Contrary to this, the 
compound 321, the inhibition effect appears to be less accentuated when using the HRP2 assay. 
 
Figure 12 – Compounds activity tested at 3 µM against P. falciparum 3D7.  
Results from depolarization detection measured at 24 h, SYBR green detection measured at 48 h and the 
HRP2 assay after 72 h of incubation. The results are expressed as normalized percentage, relative to the drug 
free control considered to represent 100% maturation or complete replication. Legend: UI – Uninfected; DF – 
Drug free; CQ100 – Chloroquine at 100nM. Arrows designate compounds for which an IC50 value was 
determined in subsequent experiments. 
 
4.5 Inhibitory concentration (IC50) values of compounds: 256, 291 and 321 
 Further experiments were performed to determine the IC50 values of three compounds, in 
particular to determine the IC50 of compound 321, which showed more than 50% inhibition in the 
depolarization assay at 3 µM (Figure 12).  Apart from compound 321, two other compounds, which 
had not shown activity, were randomly chosen (256 and 291). The IC50 values are shown in Table 
8. 
 
Table 8 - IC50 values from 256, 291 and 321 compounds 
IC50 (µM) 
Depolarization 
detection assay 
SYBR green 
detection assay 
HRP2-ELISA 
291 > 10 > 10 9.4 
256 5 4.9 3.7 
321 2 1.9 2.8 
Legend: IC50 – 50% inhibitory concentration         HRP2 – Histidine Rich Protein 2 
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 Compound 291 had the highest IC50 value of >10 µM in the flow cytometry methods and 
just below 10 µM in the HRP2-ELISA. Compound 256 showed an IC50 value of approximately 5 µM 
in the flow cytometry assays, and once again the value was slightly lower when determined by the 
HRP2-ELISA. Compound 321 which had shown inhibition at the 3 µM screening but not at the 1 µM 
screening had the lowest IC50 values that ranged from 1.96 to 2 µM in the flow cytometric assays 
and, was interestingly slightly higher, with 2.8 µM, in the HRP2-ELISA.  
 
4.6 P. falciparum 3D7 Gametocytes detection 
 Two different culture methodologies to obtain gametocytes were tested. Both were 
performed more than once, and analysed overtime by microscopic observation of culture blood 
smears and flow cytometry detection of depolarization and SYBR green.  
  
4.6.1 Results Culture Method A  
 For each time point 100.000 events were acquired. The results presented in Figure 14 
showed that the SYBR green detection, which corresponds to the parasitemia, increased until day 
four (9%), and then decreased on day five to 5%. In the following days, parasitemia started to 
progressively increase again until it reached 51% on day eleven. However, lysis of RBCs was 
observed from day four onwards, which may explain the observed decrease on day five, as well as 
the high parasitemia seen afterwards, as the total number of RBC was much reduced, as 
confirmed by FSC/SSC plots shown in Figure 13. 
Concerning the detection of the depolarization, it started at 1.3% in the culture containing 
rings, trophozoites and schizonts, reaching a first peak at day four with 4%. On day five it 
decreased to 1.6%. In the following days the percentage of depolarization started to increase until 
51% at day eleven. As already mentioned, on day eleven, there was evidence that the culture was 
mostly lysed (Figure 13). 
   In the depolarization plots (depolarized SSC/SSC) it is possible to observe, that events 
with a higher depolarization level started to appear over time (Figure 14 - B). Such degree of high 
depolarization is rarely observed in a standard continuous in vitro culture, even when there are 
mostly schizonts, Figure 14 - A. Thus, it appears to be a population with a higher degree of 
depolarization than schizonts which increases over time. 
In blood smears it was also possible to confirm the presence of gametocytes in the culture, 
at day four and during the following days. In Figure 15, representative images of the blood smears 
show the depolarization of Hz within the parasites when polarization microscopy was used. By day 
nine some depolarizing agglomerates were observed as well as fewer red blood cells. 
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Figure 13 - Forward scatter/Side Scatter results of gametocyte cultures (method A).  
A.  Plots represents an uninfcted RBCs sample and a continuous culture containing schizonts as comparison 
to B. the flow cytometric results of gametocyte cultures on days 5, 8 and 11. Forward scatter (x-axis) versus 
side scatter (y-axis). Note the disapperance of the main population on day 11, due to RBC lysis. 
 
 
These results suggest that there are gametocytes in the culture, since they should have a 
higher level of depolarization.  
However, to determine which cells are present in the higher depolarization gate, cells were 
sorted based on SYBR green fluorescence and according to their degree of depolarization. Results 
of this sorting experiment (Figure 16) show that gametocytes are indeed found exclusively in the 
upper depolarization gate. However, schizonts seems to appear in all three sorted populations, 
including those with the highest degree of depolarization where the gametocytes were also 
present. This was also corroborated by the fact that, observed in Figure 17, which shows the 
depolarization of each sorted population analysed in the Moflo, it is possible to find events from the 
medium and non-depolarizing gate in all sorted samples. 
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Figure 14 – Depolarizing events in a gametocyte culture over time (method A).  
The black line gate selects for all depolarizing events and the red line gate represents events that depolarize 
at a higher level than a culture with schizonts.  
A. Uninfected control and schizont containing culture to ilustrate gating strategy. The uninfected  sample was 
used to set the total depolarizing event gate. The synchronized schizont culture was used to define the gate 
where the higher depolarizing events would be present.  
B. Representative plots of gametocyte cultures showing an increase of events in the highly depolarizing gate 
over time. 
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Figure 15 – Blood smears of a gametocyte culture (method A).  
Representative images of a gametocyte culture on day 4, 6, 8 and 9. Ring forms (triangle arrows), schizonts 
(thin arrows) and gametocytes (thick arrows) are present as well as free Hz (within the circle). For each day a 
bright field microscopy image on the left side and a polarization microscopy image on the right are shown. 
Smears were stained with 10x Giemsa observed at an amplification of 1000x. In A. a gametocyte in stage III 
could be observed. In B. gametocytes in stage II (black arrow) and III (red arrow) could be detected. In C. a 
gametocyte in stage IV and in D. gametocytes in stage III (black arrow) and stage IV (red arrow) could be 
detected. 
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Figure 16 – Results after FACS sorting of gametocyte culture.  
A. Side Scatter (x-axis) versus depolarized Side Scatter (y-axis). Gating strategy used for sorting different 
population based on their depolarizing degree: high (H), medium (M) and non-depolarizing (N) events. Cells 
were first selected for their positive SYBR green fluorescence signal.  
B. Microscopy Images of parasites found in each sorted population. H.1 Gametocyte and H.2 schizont found 
in the high depolarizing population; M.1 Schizont found in the medium depolarizing population; N.1 Early 
schizont found among the non-depolarizing population. 
 
 
Figure 17 - Purity of sorted samples.  
The sorted populations were immediately reanalysed using the same set-up and gating strategy. 
A) Highly depolarizing events. B) Medium depolarizing events. C) Non-depolarizing events. The target 
population is present in the respective region; however, events with lower depolarization were also noted. 
For example, highly depolarizing sorted sample also showed events with medium and no depolarization 
levels.  
A) B) C) 
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4.6.2 Results culture Method B 
As an attempt to overcome the red blood cell lysis observed when using the method (A) 
described above, another gametocyte culture methodology was used. Daily flow cytometric 
assessment of the gametocyte culture was performed. Absolut counts were obtained to assess any 
decrease in the RBC population. Cultures were initiated after synchronization, representing day 
one. With this method we could not observe massive RBCs lysis until day thirteen (Figure 18). The 
flow cytometric evaluation of this gametocyte culture method (Figure 19) showed that at day four 
there were 1.6% depolarizing events. At the same day the culture reached a peak in parasitemia of 
8 %. After day four both percentage of depolarization and parasitemia started to decrease.    
However, it is possible to observe that on day five a small percentage of events with a 
higher depolarization than the schizonts appears and progressively starts to increase overtime. 
 
Figure 18 – Forward Scatter/Side Scatter results of gametocyte cultures (method B).  
A. Forward Scatter (x-axis) versus Side Scatter (y-axis) results obtained until day nine, from the experiment 
which depolarization detection results are showed as well as the culture smears images. Flow cytometric 
results of gametocyte culture on days 5, 8 and 9. First plot on the left represents a population of uninfected 
RBCs assessed during the same experiment. 
B. Forward Scatter (x-axis) versus Side Scatter (y-axis) results obtained until day thirteen, from other 
experiment. Flow cytometric results of gametocyte culture on days 4, 10 and 13. First plot on the left 
represents a population of uninfected RBCs assessed during the same experiment. 
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Figure 19 – Depolarizing events in a gametocyte culture over time (method B).  
The black line gate selects for all depolarizing events and the red line gate represents events that depolarize 
at a higher level than a culture with schizonts.  
A. Uninfected control and schizont containing culture to ilustrate gating strategy. The uninfected  sample was 
used to set the total depolarizing event gate. The synchronized schizont culture was used to define the gate 
where the higher depolarizing events would be present.  
B. Representative plots of gametocyte cultures showing an increase of events in the highly depolarizing gate 
over time 
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Importantly, gametocyte culture method B did not present the depolarizing agglomerates 
that had been observed in method A. Probably, this was caused by the major red blood cell lysis in 
method (A), which possibly led to the release of Hz. Using method B there were not changes in 
appearance of the RBCs population up to day twelve, according to their light scatter properties and 
to what was observed by microscopy (Figure 20).   
 
 
Figure 20 – Blood smears of a gametocyte culture (method B).  
Representative images of a gametocyte culture show ring forms (arrows heads), schizonts (thin arrows) and 
gametocytes (thick arrows). For each day a bright field microscopy image (left side) and a polarization 
microscopy image (right side) are shown. Smears were stained with 10x Giemsa and observed at an 
amplification of1000x. In B. a gametocyte in stage I could be observed. In C., D. and E. stage III gametocytes 
were detected, while in F. a mature gametocyte appeared. 
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5. Discussion 
 
5.1 Drug sensitivity assays 
Plasmodium falciparum has developed resistance to almost all antimalarial drugs, including 
to the artemisinins, which are the current first-line treatment of malaria. Thus, finding alternative 
compounds is most importance. According to the Malaria Eradication Research Agenda (malERA) 
[8]
 it is also important do discover/develop an antimalarial more suitable to our needs, meaning new 
drugs that prevent transmission and also relapse, but with better safety profiles than current ones. 
To search for new antimalarial drugs, sensitivity tests are used to inquire/assess the effect 
of a compound in the parasite’s growth. The available sensitivity tests used for P. falciparum 
include the WHO microtest, the hypoxantine incorporation, the pLDH or HRP2 detection, and 
fluorescence detection of the stained parasite 
[36]
. However, each of this assays have their 
limitations and/or drawbacks. Mostly, they take long incubation periods or require multiple 
incubation and washing steps. On the other hand, the microtest would not be suitable for 
compound screening since is very time consuming and it requires well-trained professionals. The 
hypoxantine incorporation method implies to work with radioactive material. Thus, there is no ideal 
sensitivity test for P. falciparum yet.  
Tough, a recent flow cytometric sensitivity assay has been proposed based on the 
detection of hemozoin (Hz) 
[49]
, due to its birefringent properties. Hz is the final bioproduct of heme 
digestion, and is accumulated inside the food vacuole of the parasite during its intra-erythrocytic 
maturation cycle 
[50]
. The idea of using Hz for a sensitivity assay is not new and was described in 
the 1980s by Rieckmann, K. H. 
[62]
. In 1999, a study using a flow cytometer based full–blood-count 
analyser, Cell Dyn (Abbottt, Santa Clara, CA) 
[63]
, that could detected Hz within leucocytes was also 
reported. Other studies showed that the Cell-Dyn seemed to detect Hz inside parasitized red blood 
cells (pRBC)
 [64], [65]
.  
Due to the birefringent properties of Hz, which causes depolarization of light, it is possible 
to detect it inside red blood cells, using an adapted flow cytometer 
[54]
. With this simple adaptation 
in one of the side scatters of the flow cytometer it is possible to detect the parasite within 
erythrocytes in a leucocyte depleted sample without using any stain or other reagent.  
The recent Hz detection sensitivity assay was used as a screening tool for compounds 
provided by Prof. Dr. Rui Moreira, from Faculdade de Farmácia da Universidade de Lisboa (FFUL). 
The compounds come from a quinazoline derivative that inhibits nuclear factor kappaB (NF-κB). 
This quinazoline derivative was one of the screen hits of Derbyshire, E. R. et al. 2012 study 
[66]
. 
Based on this quinazoline derivative, novel compounds were synthetized by Ana Ressurreição. 
These compounds had already been tested against liver stage parasites (P. berghei) and 
presented inhibitory activity, and some of them showed a low IC50 against these forms.  Therefore, 
they were tested against the blood stage P. falciparum parasites using the flow cytometric Hz 
detection assay.   
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5.1.1 P. falciparum growth in two different atmospheres (low and high oxygen) 
  Many factors like the initial parasitemia, the hematocrit, the time of incubation and the gas 
mixture, among other conditions, can influence the results of chemosusceptibility tests 
[67]
. Often a 
more complex mixture, with low O2 content is recommended. However, if results using a standard 
CO2/ambient atmosphere incubator would give comparable results, this would facilitate any culture 
experiments. Thus, the impact of the atmosphere on P. falciparum cultures growth was evaluated.  
The results showed that the obtained chloroquine (CQ) IC50 values for each incubation 
atmosphere were not very discrepant from each other (Table 6). The IC50 results were 53 and 65 
nM for depolarization and SYBR green respectively in the higher oxygenated atmosphere and 41 
nM for both methods in the low oxygen atmosphere. However, the low O2 atmosphere showed 
lower values, although less than 1xIC50 value. Interestingly, this is contrary to previous results. 
Briolant S. et al 
[68]
 observed no significant difference for the CQ IC50 values for 3D7 under 5% O2, 
10% O2 and 21% O2 atmospheres, when using the hypoxantine incorporation assay. Nonetheless, 
they observed that the parasites under 21% O2 atmosphere increased the length of schizogony 
without lethal effect on the parasite. They also observed that the mature stages had a particular 
susceptibility to high O2 concentration. In fact, the continuous culture used in our study was 
maintained in the high O2 atmosphere (standard CO2 incubator) and a subculture was transferred 
to the low O2 atmosphere for the experiment. It is possible that this culture, not being adapted to 
the low O2 may behave differently, because of the “stress” in the different atmosphere; and 
perhaps, if a culture that had been maintained in low O2 the IC50 results might be the same. 
It is common for the IC50 values to differ between assays, methods and laboratories, using 
the same strain (Table 7). However, all values are within the same order of magnitude, even 
though reported results differ from 6 nM up to 30 nM. The obtained CQ IC50 values for both 
atmospheres were higher than the ones previously published when using other methods. However, 
because we used CQ only as a control to test that measurable inhibition would occur in the 3D7 
strain, the difference may be less relevant. Likely, more meticulous attention to the preparation of 
CQ, constantly prepared fresh stock solutions, might have produced lower results.  
After the determination of CQ’s IC50 we chose a concentration of around 2x the IC50 = 100 
nM, on the basis that this would produce a marked inhibition (> IC50), yet not causing a complete 
inhibition (see Figures 11 and 12). 
Because the results for the atmosphere were not highly discrepant, the compounds from 
FFUL were screened using a standard CO2 incubator with a 21% O2 atmosphere (ambient 
atmosphere). 
 
5.1.2 Screening results 
The compounds from FFUL were screened using two flow cytometry methods: the recent 
sensitivity flow cytometric assay for Hz detection and the SYBR green detection. To corroborate 
the obtained results with this novel method, compounds were also tested with the already validated 
HRP2 method (only for the 3D7 strain – see point 3.3.6). 
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It should be noted that currently used antimalarial drugs have IC50 values in the low nM 
range, with CQ in the 10 - 30 nM, while drugs such as artemisinins may have IC50s even below 1.0 
nM 
[69], [70]
. Having said this, a single concentration, like 1 µM (=1000 nM), is often used as the 
screening concentration for novel compounds and it is rarely extended to 10 mM (value at which 
unspecific toxic effects may supplant specific antimalarial effects) 
[71]
. As suggested by some 
researchers 
[72] [73]
, when a compound has activity at 1µM then the IC50 should be determined, and 
ought to be ideally below 1 µM. However, in our experiments none of the compounds had an effect 
at 1 µM. This is not too unexpected, as the compounds were primarily designed to act against liver 
stages, yet they might have also showed inhibitory effects against the asexual blood stages. 
However, because some compounds had been screened before and shown some inhibition at 10 
µM, we proceeded to test all compounds also at 3 µM concentration. Only one compound, 321, 
showed a major inhibitory effect at the higher concentration (see Figure 12 and Table 8). 
 
5.1.3 P. falciparum: use of strains Dd2 and 3D7  
 The P. falciparum strains Dd2 and 3D7 were used for compound screening. There are a 
variety of P. falciparum isolated strains that can be used in laboratory research. They can be 
divided into chloroquine-sensitive, like 3D7, and chloroquine-resistant strains such as the Dd2 
strain. Since different strains are genetically different, they can behave differently in the presence 
of antimalarial drugs, being relevant to test new compounds against more than one strain 
[74]
. 
Certainly, one can argue to use the resistant Dd2 strain for screening to find compounds that would 
already act against P falciparum forms, most of which are already resistant to CQ. On the other 
hand, using this strain may miss some compound leads which show activity only against CQ 
sensitive strains, the reason while many researchers use the 3D7 strain. In fact, because some 
compounds had been screened elsewhere before, using the Dd2 and had showed no activity, we 
decided to confirm these results first using the Dd2, and then repeating the screening process 
using the more sensitive 3D7 strain to make sure that no potential activity would be missed. 
Therefore, two different strains were used to perform the screening assays, one 
chloroquine-sensitive (3D7) and the other chloroquine-resistant (Dd2).  
 
5.1.4 Sensitivity assays: analysis of depolarization and SYBR green detection and 
HRP2-ELISA 
The results for the Dd2 strain were obtained only by flow cytometric methods: the 
hemozoin depolarization detection and the SYBR green detection. In general, none of the tested 
compounds presented a marked inhibitory action against this strain. As it is possible to observe in 
the results, according to the SYBR green stain, which measures parasite replication, the parasite 
always grew more than 100 % in the presence of the compound. With the depolarization assay, 
which measures maturation, parasites also showed > 80% growth rate in the presence of the 
compound.  Thus, with both assays it was possible to observe that the CQ control, at 100 nM, had 
no action against this Dd2 strain, which was expected because it is a CQ resistant strain, as 
mentioned above. However, one limitation of the Dd2 experiment is that an effective drug that 
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could inhibit Dd2 parasite growth, such as mefloquine, quinine or perhaps artemisinin should have 
been used as a positive drug control. 
Then, all compounds were tested against the 3D7 P. falciparum strain. Overall, none of the 
compounds presented any marked inhibitory action at 1 µM concentration with this strain, 
regardless of the used method. In fact, to validate the flow cytometry assay’s performance, while 
testing the FFUL compounds against the 3D7 strain, the HRP2-ELISA was also performed. The 
parasite growth in the presence of the FF compounds was always above 80 %. According to the 
depolarization assay, in 18 tested compounds (75%) the parasite had a growth higher than 100%. 
With the SYBR green detection assay, parasite growth was also higher than 100% in 15 of the 
tested compounds (62.5%). However with the HRP2 method parasite growth was never higher 
than 100%. A possible reason for this larger variation on the Hz and SYBR green assay is, that 
both detect growth changes much earlier, and are more susceptible to small changes, while than 
the HRP2, which is based on the detection of HRP2 produced during a 72 h period. Thus, in the 
HRP2 assay variability may be less pronounced. 
On the other hand, when comparing the results, it appears that the cytometric approaches 
may be more sensitive to detect small inhibitory effects. For example, the only evident active 
compound at 3 µM (321) showed inhibition of 62% and 72% in the flow cytometric depolarization of 
Hz and SYBR green, respectively. However, in the HRP2 the detected inhibition was only of 39%. 
This could be explained by the fact that the background production of HRP2 over the long 
incubation period of 72h may mask some smaller inhibitory effects.  
Thus, it appears that all three methods would have been useful to screen the compounds. 
Still the novel flow cytometric methods, despite a larger inter-compound variability may be more 
suitable to detect discrete inhibitory effects, which may be masked by assays with long incubation 
periods, such as the HRP2 assay 
[75]
. 
Certainly according with the results, it is possible to conclude that none of the compounds 
would present an IC50 value below 1 µM, and consequently, none appears to be appropriate for 
further studies in vivo as an antimalarial drug. Though the compound 321 showed IC50 values 
(Table 8) in the lower µM range is too high to be therapeutically useful, but it may eventually allow 
pharmaceutical evaluation of this compound to investigate what makes this molecule more active 
than all the other ones. 
Concerning the differences which are present between the used sensitivity assays further 
points have to be considered. First, the initial hematocrit was different between the flow cytometric 
approaches and the HRP2 assay as well as the initial parasitemia, which inherent due to the 
respective protocols. One consequence could be the inoculum effect 
[49], [76], [77]
, due to different 
amounts of parasites being exposed to a specific drug concentration. Second, the parasite 
presence is measured at different times of its development in each method. In fact, Hz detection is 
performed during growth at 24 h, SYBR green measures replication at the end of the first cycle at 
48 h, while HRP2 production is measured into the second cycle at 72 h only. Furthermore, in the 
flow cytometric methods, measurements are done on a single cell basis, and thus variation is much 
more influenced by the total number of cells which are analyzed (in our experiments 1000.000 cells 
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were analyzed per assay). On the other hand, with the HRP2 method, the parasite growth is 
measured on the whole population, because the detected HRP2 is present in the culture 
suspension. In fact, the number of parasites which are analyzed by each method can be calculated 
(Table 9). Doing this shows that the Hz detection assay only needs to analyze a fraction of the 
parasites to obtain results, although this also explains again, the higher variability which was 
observed. 
Thus, flow cytometric methods are probably more favorable to subtle variations on the 
proportion of parasites detected/counted in each sample, relativity to the HRP2-ELISA. With the 
HRP2-ELISA, the total amount of protein produced by the parasites during the 72 h of incubation is 
detected, enabling a more global measurement of the parasite presence in each well. 
 
Table 9 – Differences between methods 
 
Hemozoin 
detection 
SYBR green detection HRP2 
Initial parasitemia 1 % 1 % 0.05 % 
Hematocrit 2.5 % 2.5 % 1.5 % 
Data aquisition 24 h 48 h 72 h 
Detection 
Single detection 
Cell by  cell 
Single detection 
Cell by cell 
Whole 
population 
Number of parasites 
contributed/analysed per assay*  
~1000 4000-8000 ~1.200.000 
*calculation: 
Hemozoin assay   100.000 events analysed x ~1 % parasitemia = ~1000 parasites 
SYBR green assay  100.000 events analised X 4-8 % parasitemia = 4000 – 8000 parasites 
HRP2-ELISA     1.5 % hematocrit ~ 120.000 cells/ µL 
     200 µL  ~24 million cells 
     0.05 % parasitemia  ~1.200.000 parasites 
     Note: 50 % hematocrit ~ 4 million cell/µL 
 
Because the compounds are quinazoline derivatives that inhibit the NF-kB activation, they 
are likely to interfere with DNA synthesis (transcription) 
[78]
. The drugs that inhibit DNA synthesis 
are suitable to inhibit cells or microorganisms with a fast replication rate. However, P. falciparum 
has a rather slow replication rate, 48 h before a new cycle starts. Thus, it may be that the 
compounds exhibit no discernable action or only slight inhibitory action, as seen in this work. 
 Overall, the results from the screened compounds appear to agree between the used 
methods. Moreover, it is possible to affirm that none of the tested FFUL compounds have inhibitory 
action at a suitable antimalarial concentration, in the nM range. However, with the recently 
developed sensitivity assay, based on the flow cytometric detection of Hz, it was possible to obtain 
comparable results in 24 h, based on the analysis of just <1000 infected RBCs.  
The Hz detection assay can detect inhibitory action of drugs quickly and early, specially 
those that inhibit Hz formation 
[49]
. On the other hand, slow acting drugs effect, like pyrimethamine, 
Each well: 
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an antifolate drug that interferes with DNA synthesis, is usually only detected in the second 
generation 
[49]
. However, analyzing the results obtained with compound 321 and assuming that this 
action is also based on DNA inhibition, the Hz assay reliably detected this inhibitory effect already 
after 24 h of incubation, as compared with the already validated HRP2 assay. 
However, potential drawbacks of this novel method is that it is not possible to use low 
starting  parasitemias as the ones used the HRP2-ELISA, because the lower detection limit has 
been reported to be around 0.3 % parasitemia 
[49]
. Another downside of this method is related with 
the fact that, although it detects inhibitory action of novel compounds, it is not yet well suitable for 
the high-throughput screening of compounds since the flow cytometric acquisition of samples is 
time consuming. Commonly, antimalarial drugs screening is based on the IC50 determination for 
each tested compound 
[72], [73]
. However, without an improvement in the way samples can be 
acquired in the flow cytometer, the determination of IC50 values for a large scale screening would 
be difficult. 
Nevertheless, flow cytometry offers the opportunity to provide more information about 
malaria parasite growth and development than most other currently available methods. The 
hypoxantine incorporation, the ELISA based assays and the indicators of DNA quantity assays 
(fluorometric) all have the same shortfalls which are that they cannot detect easily stage specific 
effects 
[44]
.  
   
5.2 Gametocytes detection 
During the blood cycle of P. falciparum, a few merozoites differentiate into gametocytes. 
Environmental factors, normally a condition which constitute some kind of “stress”, influence the 
commitment to sexual development of the parasite. Factors like host immunity, anemia, drug 
treatment among others can be considered to trigger gametocytogenesis 
[59]
. In the gametocyte 
maturation there are five characteristic stages: I, II, III, IV and V, (Table 10) 
[59]
. During this 
maturation process Hz is also formed and accumulated inside gametocytes, however its 
distribution is rather different to the one observed in asexual forms (Figure 4).  
Because gametocyte inhibitory drugs are needed, sensitivity drug tests for the screening of 
compounds against these forms are also required. Currently available assays are highly complex 
and difficult to perform. The gametocyte drug screening assays can be divided into four categories: 
those that assay gametocytogenesis 
[79], [80]
; those that focus on gametocyte development 
[81]
; those 
that assay for lethal activity against the mature gametocyte, either with an ATP production readout 
[82], [83]
, or stage-specific GFP expression 
[81]
; and finally those that assay the onward development 
of mature gametocytes 
[84]
. 
Because Hz pigment is not only abundant in gametocytes of P. falciparum, but it also has a 
different distribution compared with asexual forms, the assumption was that this novel sensitivity 
assay based on the Hz detection could also be applied to detect gametocytes. P. falciparum 
gametocytes particularly have the Hz crystal not organized into a single aggregate, as it is usually 
seen in mature schizonts, but rather in many smaller, dispersed fragments. Because side scatter is 
a measure of granularity/dispersion of particles, this would predict that the Hz crystals in 
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gametocytes would present a different profile in the depolarized side scatter as compared to other 
asexual forms. Due to this characteristic it was expected that gametocytes would be found in the 
depolarized side scatter showing a higher level of depolarization.  However, before this detection it 
was necessary to test culture conditions which would produce sufficient number of gametocytes. 
 
Table 10 - Gametocyte maturation stages: characteristics and images  
Stage I 
IA: Indistinguishable trophozoite. 
IB: Larger round shape, distinguished by granular distribution of 
pigment in food vacuole  
Stage II 
IIA: elongates within the erythrocyte 
IIB: D shaped 
 
Stage 
III 
D shaped, slightly distorted erythrocyte Pink/blue distinction of the 
male/female gametocytes. 
 
Stage 
IV 
Elongated and thin parasite, distorted red cell. Male gametocyte: 
pigment tends to be scattered; in female gametocytes: pigment more 
dense 
 
Stage 
V 
Sausage shaped parasite with rounded extremities. Male gametocyte: 
pigment scattered, pink aspect (Giemsa stain) Female gametocyte: 
dense pigment, light violet 
 
Based on Talman, A. M., et al. 2004 
[59]
,
 
and Carter, R. and Miller, L. H., 1979 
[85]
 
 
5.2.1 Gametocytes cultures 
Different techniques to culture gametocytes have been described 
[86]
. Two different ways to 
culture and obtain purified P. falciparum 3D7 gametocytes were used in this study. One based on 
the procedure described in Methods on Malaria Research 
[87]
 (method A) and another based on 
Roncalés, M. et al 
[86]
 research (method B). The cultures were followed on a daily basis using 
microcopy smears and flow cytometry evaluation.  
Results showed that, although the described protocols affirm that usually the peak of 
mature gametocytes tend to appear only around days 14-15, it was possible to observe and detect 
them earlier. However, important differences can be observed between the methods used in this 
study. For instance, with the culture method A, massive RBC lysis occurred around day eleven, 
well before the time when the peak of mature gametocytes is supposed to be present. Even more, 
with this method, the cultured parasites seems to die, because at the end (day eleven) very few 
parasites and red blood cells were present (Figure 13). However, many free depolarizing 
agglomerates were observed in depolarization microscopy, and these tended to group together. 
Therefore, these clusters had the aspect of free Hz crystals and clustering would not be too 
surprising, because Hz crystals are known to have very strong adherent properties 
[88] 
and thus, to 
stick together.  
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Consequently, due to the great amount of free Hz that accumulated in the culture over 
time, interference with the depolarized side scatter would be expected. In fact, great number of 
depolarizing events was detected in the depolarized side scatter. 
Then, to improve the purity of gametocyte stages in a culture, another method was tried 
(method B). With this method it was possible to maintain the culture for a longer period without 
major RBC lysis, giving time for the gametocytes to mature through all the five stages. It was also 
possible to detect a higher population of events in the depolarizing side scatter which had never 
been observed in previous schizont cultures (Figures 14 and 19). However, with this culture 
method the amount of depolarizing events, especially in the highest region, is much less than the 
previous method. Still, this may confirm our notion that most events which were detected in the 
previous culture condition were in fact free Hz, as explained above. 
 The way gametocytes were cultured need to be improved or other methods have to be 
established so that it is possible to have more gametocytes in culture, before one can think about 
drugs that could be tested against the gametocytes stages. This relates to the fact that different 
compounds act in different stages of commitment of the gametocyte, and with different impact on 
the sex of gametocytes 
[89]
. Ways to improve gametocytes culture comprise the use of recently 
isolated strains that, according to several authors are more likely to form gametocytes than strains 
that have been in culture for long periods of time. Another way may be the use of P. falciparum 
NF54 strain, since different strains present different capacities to generate gametocytes 
[86]
. 
 
5.2.3 Detection of gametocytes using side scatter depolarization 
Gametocytes were obtained and were present in culture using both methods. By day 6, a 
Fluorescence-activated cell sorting (FACS) was preform to investigate if the depolarizing 
characteristic of the gametocytes would be found in the highest depolarizing region. In fact, 
gametocyte stages, although in very low numbers, were only found in high depolarizing population. 
However, other parasite stages like schizonts were also found in the same population. 
Unexpectedly, since all events had been selected on their SYBR green positivity, agglomerates 
were also found in the sorted population, meaning that they should have DNA attached. In fact, it is 
known that Hz has strong absorptive properties and can bind DNA easily, so it is possible that 
these Hz agglomerates had free DNA bound to them 
[88]
. 
Schizonts were also found in the middle and non-depolarizing gates (Figure 16). This 
relates to the purity of each sorted population. As it is possible to find in the figure of population 
purity, the sorted upper population does not only depolarize in a restricted higher region but along 
the depolarization detection axis. In the sorted population from the non-depolarizing gate, schizont 
forms were also found, and once again, according to the purity data, a small group of events seem 
to depolarize.  
The FACS sorting was performed using a Moflo flow cytometer due to the fact that it is one 
of the few flow cytometry sorters which can be set up to detect depolarized light scatter. Other 
sorters, like FACSAria do not detect depolarization, given that the light travels to the detectors 
through fiber-optical cables, and the polarization of the incident light beam is lost. However, to use 
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the MoFlo sorter, the gametocyte culture sample had to be fixed for safety reasons. Fixing a culture 
implies that red blood cells become autofluorescent, contrary to the unfixed RBCs 
[44]
. This could 
introduce additional difficulties when choosing the SYBR green positive population. However, this 
effect was negligible in our previous experiments. 
It is also true that the ratio of parasites that commit to differentiation into gametocytes is 
very low 
[90]
. Thus it is not unlikely that the few depolarizing events which were observed are indeed 
gametocytes. However, only preforming sorting after growing gametocytes in sufficient numbers 
and confirming that they are only present in the higher depolarizing population would definitely 
proof this concept. Of note, using nucleic acid double staining it might be possible to corroborate 
this hypothesis as well. Combining Hoechst 33342, a DNA stain, with a RNA selective stain like 
Pyronin Y, we could eventually detect the gametocytes nucleic acid profile, since in the gametocyte 
development, probably there is no DNA replication but RNA synthesis 
[61], [91]
.    
Overall, in this first approach it was possible to confirm the basic hypothesis that 
gametocytes can be found in a specific region based on their depolarization side-scatter, which is a 
consequence of their particular Hz distribution.  
6. Conclusion 
 Using the novel flow cytometric method based on the detection of infected red blood cells 
containing Hz, inhibitory effect of several new antimalarial drugs could be assessed as reliably as 
the two other performed assays (SYBR green staining and HRP2-ELISA). This screening allowed 
concluding that none of the compounds had an inhibitory activity below 1 µM concentration. 
Though, form the 24 screened compounds there was one (321) with an IC50 around 2 µM, once 
more in agreement with the three sensitivity assays performed.  
Using this adapted flow cytometer to detect Hz also enabled to detect gametocytes, 
according to their depolarization properties. In fact, gametocytes had a higher depolarized side-
scatter signal, since these forms have several, small and dispersed Hz crystals. However, 
additional work is required to improve the gametocytes culture method so higher numbers of 
gametocytes can be obtained. After this, gametocytes could be treated with different drugs, 
including newly synthetized compounds, thus establishing a novel in vitro sensitivity assay for 
transmission blocking drugs.  
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